Author:
Haoula Zeina,Ravipati Srinivasarao,Stekel Dov J.,Ortori Catharine A.,Hodgman Charlie,Daykin Clare,Raine-Fenning Nick,Barrett David A.,Atiomo William
Publisher
Springer Science and Business Media LLC
Subject
Clinical Biochemistry,Biochemistry,Endocrinology, Diabetes and Metabolism
Reference38 articles.
1. Atiomo, W., & Daykin, C. A. (2012). Metabolomic biomarkers in women with polycystic ovary syndrome. A pilot study. Molecular Human Reproduction, 18, 546–553.
2. Atiomo, W., Khalid, S., Parameshwaran., Houda, M., & Layfield, R. (2009a). Proteomic biomarkers for the diagnosis and risk stratification of polycystic ovary syndrome: A systematic review. BJOG: An International Journal of Obstetrics and Gynaecology, 116, 137–143.
3. Atiomo, W. U., Khalid, S., Ziauddin, A., Tooth, D., & Layfield, R. (2009b). Framework for a systems approach to proteomic biomarker profiling in polycystic ovary syndrome. Expert Review of Proteomics, 6, 469–499.
4. Banaszewska, B., Antoni, J., Pawelczyk, L., Robert, Z., & Spaczynski, Z. (2006). Lipids in polycystic ovary syndrome role of hyperinsulinemia and effects of metformin. Journal of Obstetrics and Gynaecology, 194, 1266–1272.
5. Bloom, M. S., Schisterman, E. F., & Hediger, M. L. (2007). The use and misuse of matching in case-control studies: The example of polycystic ovary syndrome. Fertility and Sterility, 88(3), 707–710.
Cited by
47 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献